Drug Discrimination in Neurobiology
Tóm tắt
Từ khóa
Tài liệu tham khảo
Altman, 1977, Drugs as discriminable events in humans, 187
Amrick, 1987, N-Methyl-d-aspartate produces discriminative stimuli in rats, Life Sci., 40, 585, 10.1016/0024-3205(87)90373-0
Ariëns, E. J.: The mode of action of biologically active compounds. In: Molecular pharmacology, vol. 1. New York: Academic Press; 1964.
Balster, 1987, Abuse potential evaluation of inhalants, Drug Alcohol Depend., 19, 7, 10.1016/0376-8716(87)90082-2
Barrett, 1983, Drug discrimination in rats, Pharmacol. Biochem. Behav., 18, 611, 10.1016/0091-3057(83)90289-7
Barrett, 1992, Tolerance, withdrawal and supersensitivity to dopamine mediated cues in a drug-drug discrimination, Psychopharmacology (Berlin), 109, 63, 10.1007/BF02245481
Barry, 1977, Discriminable stimuli produced by alcohol and other CNS depressants, 73
Bartoletti, 1989, Time-dependent generalization of morphine stimulus properties to meperidine, Pharmacol Biochem. Behav., 34, 429, 10.1016/0091-3057(89)90338-9
Bennett, 1982, Discriminative stimulus properties of the vasodilator, hydralazine, Prog. Neuropsychopharmacol. Biol. Psychiatry, 6, 17, 10.1016/S0364-7722(82)80103-3
Bertalmio, 1987, Differentiation between mu and kappa receptor mediated effects in opioid drug discrimination, J. Pharmacol. Exp. Ther., 243, 591
Bickel, 1989, Opioid drug discrimination in humans, J. Pharmacol. Ther., 251, 1053
Coffin, 1983, Behavioral pharmacology of adenosine analogs, 267
Colpaert, 1975, Investigations on drug produced and subjectively experienced discriminative stimuli. 1. The fentanyl cue, a tool to investigate subjectively experienced narcotic drug actions, Life Sci., 16, 705, 10.1016/0024-3205(75)90347-1
Colpaert, 1975, Investigations on drug produced and subjectively experienced discriminative stimuli. 2. Loperamide, an antidiarrheal devoid of narcotic cue producing actions, Life Sci., 16, 717, 10.1016/0024-3205(75)90348-3
Colpaert, 1975, Apomorphine as a discriminative stimulus, and its antagonism by haloperidol, Eur. J. Pharmacol., 32, 383, 10.1016/0014-2999(75)90310-6
Colpaert, 1976, Discriminative stimulus properties of benzodiazepines, barbiturates and pharmacologically related drugs; Relation to some intrinsic and anticonvulsant effects, Eur. J. Pharmacol., 37, 113, 10.1016/0014-2999(76)90014-5
Colpaert, 1976, Discriminative stimulus properties of fentanyl and morphine, Pharmacol. Biochem. Behav., 5, 401, 10.1016/0091-3057(76)90103-9
Colpaert, 1976, Blockade of apomorphine's discriminative stimulus properties, Pharmacol. Biochem. Behav., 5, 671, 10.1016/0091-3057(76)90310-5
Colpaert, 1976, Theoretical and methodological considerations on drug discrimination learning, Psychopharmacologia, 46, 164, 10.1007/BF00421388
Colpaert, 1976, On the ability of narcotic antagonists to produce the narcotic cue, J. Pharmacol. Exp. Ther., 197, 180
Colpaert, 1976, The narcotic discriminative stimulus complex, J. Pharmacol. Pharmacol., 28, 183, 10.1111/j.2042-7158.1976.tb04127.x
Colpaert, 1976, Discriminative stimulus properties of analgesic drugs, Arch. Int. Pharmacodyn. Thér., 220, 329
Colpaert, 1976, Cocaine cue in rats as it relates to subjective drug effects, Eur. J. Pharmacol., 40, 195, 10.1016/0014-2999(76)90372-1
Colpaert, 1976, Experimental approach to the evaluation of drug abuse liability, 251
Colpaert, 1977, Drug-produced cues and states, 5
Colpaert, 1978, Discriminative stimulus properties of narcotic analgesic drugs, Pharmacol. Biochem. Behav., 9, 863, 10.1016/0091-3057(78)90370-2
Colpaert, 1978, Narcotic cuing and analgesic activity of narcotic analgesics, Psychopharmacology (Berlin), 57, 21, 10.1007/BF00426952
Colpaert, 1978, Neuroleptic interference with the cocaine cue, Psychopharmacology (Berlin), 58, 247, 10.1007/BF00427387
Colpaert, 1978, Studies on the regulation of sensitivity to the narcotic cue, Neuropharmacology, 17, 705, 10.1016/0028-3908(78)90084-9
Colpaert, 1978, Changes of sensitivity to the cuing properties of narcotic drugs as evidenced by generalization and cross-generalization experiments, Psychopharmacology (Berlin), 58, 257, 10.1007/BF00427388
Colpaert, 1978, Discriminative stimulus properties of cocaine and d-amphetamine, and antagonism by haloperidol, Neuropharmacology, 17, 937, 10.1016/0028-3908(78)90135-1
Colpaert, 1978, Nociceptive stimulation prevents development of tolerance to narcotic analgesia, Eur. J. Pharmacol., 49, 335, 10.1016/0014-2999(78)90114-0
Colpaert, 1978, Factors regulating drug cue sensitivity. A long-term study on the cocaine cue, 281
Colpaert, F. C.: Rosecrans, J. A., eds. Stimulus properties of drugs: Ten years of progress. Amsterdam: Elsevier/North Holland Biomedical Press; 1978.
Colpaert, 1978, Narcotic cue, narcotic analgesia, and the tolerance problem, 301
Colpaert, 1979, Can chronic pain be suppressed despite purported tolerance to narcotic analgesia, Life Sci., 24, 1201, 10.1016/0024-3205(79)90057-2
Colpaert, 1979, Discriminative stimulus properties of cocaine, Pharmacol. Biochem. Behav., 10, 535, 10.1016/0091-3057(79)90229-6
Colpaert, 1979, In vivo evidence of partial agonist activity exerted by purported 5-hydroxytryptamine antagonists, Eur. J. Pharmacol., 58, 505, 10.1016/0014-2999(79)90326-1
Colpaert, 1980, Factors regulating drug cue sensitivity, J. Pharmacol. Exp. Ther., 2, 474
Colpaert, 1980, Evidence that a preferred substrate for type B monoamine oxidase mediates stimulus properties of MAO inhibitors, Pharmacol. Biochem. Behav., 13, 513, 10.1016/0091-3057(80)90273-7
Colpaert, 1981, Factors regulating drug cue sensitivity, Arch. Int. Pharmacodyn. Ther., 254, 241
Colpaert, 1982, Factors regulating drug cue sensitivity, Arch. Int. Pharmacodyn. Ther., 258, 283
Colpaert, 1982, A drug discrimination analysis of lysergic acid diethylamide, J. Pharmacol. Exp. Ther., 221, 206
Colpaert, 1983, The head-twitch response to intraperitoneal injection of 5-hydroxytryptophan in the rat, Neuropharmacology, 22, 993, 10.1016/0028-3908(83)90215-0
Colpaert, 1983, A characterization of LSD-antagonist effects of pirenperone in the rat, Neuropharmacology, 22, 1001, 10.1016/0028-3908(83)90216-2
Colpaert, 1984, Agonist and antagonist effects of prototype opiate drugs in rats discrimination fentanyl from saline, J. Pharmacol. Exp. Ther., 230, 193
Colpaert, 1984, A possible a2-adrenergic component in the in vivo action of pirenperone, Eur. J. Pharmacol., 103, 169, 10.1016/0014-2999(84)90206-1
Colpaert, 1985, Discriminative stimulus properties of xylazine in rat, J. Pharmacol. Exp. Ther., 235, 521
Colpaert, 1986, Drug discrimination, 161
Colpaert, 1986, Agonist and antagonist effects of prototype opiate drugs in fentanyl dose-dose discrimination, Psychopharmacology (Berlin)., 90, 222, 10.1007/BF00181246
Colpaert, 1987, Drug discrimination, 341
Colpaert, 1987, Evidence that adjuvant arthritis in the rat is associated with chronic pain, Pain, 28, 201, 10.1016/0304-3959(87)90117-5
Colpaert, 1988, Intrinsic activity and discriminative effects of drugs, 154
Colpaert, 1991, The discriminative response, Behav. Pharmacol., 2, 283, 10.1097/00008877-199109000-00004
Colpaert, 1995, Drug discrimination, Pharmacol. Rev., 47, 605
Colpaert, 1995, Empirical evidence that the state dependence and drug discrimination paradigms can generate different outcomes, Psychopharmacology (Berlin), 120, 272, 10.1007/BF02311174
Colpaert, 1996, System theory of pain and of opiate analgesia, Pharmacol. Rev., 48, 355
Cone, 1984, Shannon, H. E., J. Pharmacol. Exp. Ther., 228, 147
Cunningham, 1988, Hallucinogenic and non-hallucinogenic 5-HT agonists, 217
De Vry, 1984, Effects of drug-induced differences in reinforcement frequency on discriminative stimulus properties of fentanyl, Psychopharmacology (Berlin), 83, 257, 10.1007/BF00464790
Druhan, 1990, Amphetamine-like stimulus properties produced by electrical stimulation of reward sites in the ventral tegmental area, Behav. Brain Res., 38, 175, 10.1016/0166-4328(90)90015-7
Egan, 1998, Agonist activity of LSD and lisuride at cloned 5-HT2A and 5-HT2C receptors, Psychopharmacology (Berlin), 136, 409, 10.1007/s002130050585
Eich, 1977, State-dependent retrieval of information in human episodic memory
Evans, 1991, CNS depressant effects of volatile organic solvents, Neurosci. Biobehav. Rev., 15, 233, 10.1016/S0149-7634(05)80003-X
France, 1984, Discriminative stimulus effects of reversible and irreversible opiate agonists, J. Pharmacol. Exp. Ther., 230, 652
France, 1985, Opiate agonist-antagonist interactions, J. Pharmacol Exp. Ther., 234, 81
France, 1987, Comparison of naltrexone and quaternary naltrexone after systemic and intracerebroventricular administration in pigeons, Neuropharmacology, 26, 541, 10.1016/0028-3908(87)90145-6
France, 1994, Drug discrimination as a model for studying opioid dependence and withdrawal in animals, 281
Gellert, 1979, Discriminative stimulus effects of naltrexone in the morphine-dependent rat, J. Pharmacol. Exp. Ther., 211, 596
Glennon, 1980, Hallucinogenic agents as discriminative stimuli, Psychopharmacology (Berlin), 68, 154, 10.1007/BF00432133
Glennon, 1984, Hallucinogenic phenylisopropylamines, 327
Glennon, 1984, structure–activity studies on amphetamine analogs using drug discrimination methodology, Pharmacol. Biochem. Behav., 21, 895, 10.1016/S0091-3057(84)80071-4
Glennon, 1984, Evidence for 5HT2 involvement in the mechanism of action of hallucinogenic agents, Life Sci., 35, 2505, 10.1016/0024-3205(84)90436-3
Glennon, 1986, Discriminative stimulus properties of the 5-HT1A agonist 8-hydroxy-2-(di-N-propylamino)tetralin (8-OH DPAT), Pharmacol. Biochem. Behav., 25, 135, 10.1016/0091-3057(86)90243-1
Glennon, 1987, The study of structure–activity relationships using drug discrimination methodology, 373
Goudie, 1985, Temporal parameters of the discriminative stimulus and rate-suppressant properties of the psychostimulant dl-cathinone possible relevance to prediction of drug dependence potential, IRCS Med. Sci., 13, 966
Herling, 1981, Discriminative stimulus effects of narcotics, Life Sci., 28, 1571, 10.1016/0024-3205(81)90311-8
Herling, 1981, Similarity of the discriminative stimulus effects of ketamine, cyclazocine, and dextrophan in the pigeon, Psychopharmacology (Berlin), 73, 286, 10.1007/BF00422419
Himmelweit, F., ed. The collected papers of Paul Ehrlich. London: Pergamon Press; 1956.
Ho, 1978, Stimulants as discriminative stimuli, 53
Holohean, 1982, Dopaminergic and serotonergic mediation of the discriminable effects of ergot alkaloids, Eur. J. Pharmacol., 81, 595, 10.1016/0014-2999(82)90349-1
Holtzman, 1980, Phencyclidine (PCP)-like discriminative effects of opioids in the rat, Fed. Proc., 39, 994
Holtzman, 1983, Discriminative stimulus properties of opiate drugs, 1
Holtzman, 1985, Discriminative stimulus properties of opioids that interact with mu, kappa and PCP/sigma receptors, 131
Holtzman, 1985, Discriminative stimulus effects of morphine withdrawal in the dependent rat, J. Pharmacol. Exp. Ther., 233, 80
Holtzman, 1986, Discriminative stimulus properties of caffeine in the rat noradrenergic mediation, J. Pharmacol. Exp. Ther., 239, 706
Holtzman, 1988, Neural mechanisms of drug stimuli, 139
Jackson, 1992, NMDA antagonists make learning and recall state-dependent, Behav. Pharmacol., 3, 415, 10.1097/00008877-199208000-00018
Jarbe, 1976, Characteristics of tetrahydrocannabinol (THC)-produced discrimination in rats, Psychopharmacology (Berlin), 48, 181, 10.1007/BF00423258
Jarbe, 1977, Alcohol-discrimination in gerbils, Arch. Int. Pharmacodyn., 227, 118
Jarbe, 1989, Subjectively experienced cannabis effects in animals, Drug Dev. Res., 16, 385, 10.1002/ddr.430160232
Johansson, 1976, Physostigmine as a discriminative cue in rats, Arch. Int. Pharmacodyn., 219, 97
Jung, 1987, Discriminative stimulus properties of muscarinic agonists, Psychopharmacology (Berlin), 93, 139, 10.1007/BF00179923
Jung, 1987, Effects of intracerebroventricular pirenzepine on muscarinic discriminations in rats, Eur. J. Pharmacol., 139, 111, 10.1016/0014-2999(87)90504-8
Kamien, 1987, Discriminative stimulus properties of D1 and D2 dopamine agonists in rats, J. Pharmacol. Exp. Ther., 242, 804
Koek, 1982, Effects of reinforcement differences between drug and saline sessions on discriminative stimulus properties of fentanyl, 343
Koek, 1989, Partial generalization in pigeons trained to discriminate morphine from saline, Drug Dev. Res., 16, 169, 10.1002/ddr.430160211
Koek, 1993, Effects of phencyclidine-type drugs in rats discriminating fentanyl from saline, J. Pharmacol. Exp., Ther., 264, 746
Koek, 1995, Effects of the NMDA antagonist, dizocilpine, in various drug discriminations, Behav. Pharmacol., 6, 590, 10.1097/00008877-199508000-00019
Koek, 1998, F 11440, a potent selective, high efficacy 5-HT1A agonist with marked anxiolytic and antidepressant potential, J. Pharmacol. Exp. Ther., 287, 266
Kuhn, 1977, Discriminative stimulus properties of hallucinogens, 137
Levesque, 1994, Discriminative stimulus effects of melatonin in the rat, Psychopharmacology (Berlin), 116, 167, 10.1007/BF02245059
Marek, 1996, LSD and the phenethylamine hallucinogen DOI are potent partial agonist at 5-HT2A receptors on interneurons in rat piriform cortex, J. Pharmacol. Exp. Ther., 278, 1373
McMillan, 1984, Bias of phencyclidine discrimination by the schedule of reinforcement, J. Exp. Anal. Behav., 42, 51, 10.1901/jeab.1984.42-51
Meert, 1989, Risperidone (R 64 766), a potent and complete LSD antagonist in drug discrimination by rats, Psychopharmacology (Berlin), 97, 206, 10.1007/BF00442251
Meert, 1990, Pharmacological validation of ritanserin and risperidone in the drug discrimination test procedure in the rat, Drug. Dev. Res., 19, 353, 10.1002/ddr.430190403
Melton, 1994, Receptor mediation of the stimulus properties of cholecystokinin, Pharmacol. Biochem. Behav., 48, 275, 10.1016/0091-3057(94)90527-4
Nielsen, 1985, Antagonism of the amphetamine cue by both classical and atypical antipsychotic drugs, Eur. J. Pharmacol., 111, 167, 10.1016/0014-2999(85)90753-8
Nielsen, 1986, Cueing effects of amphetamine and LSD, Eur. J. Pharmacol., 125, 85, 10.1016/0014-2999(86)90086-5
Oberlender, 1984, Substituent branching in phenethylamine type hallucinogens, J. Med. Chem., 27, 788, 10.1021/jm00372a015
O'Donnell, 1997, Pharmacological characterization of the discriminative stimulus effects of clenbuterol in rats, Pharmacol. Biochem. Behav., 58, 813, 10.1016/S0091-3057(97)00038-5
Overton, 1966, State-dependent learning produced by depressant and atropine-like drugs, Psychopharmacology (Berlin), 10, 6, 10.1007/BF00401896
Overton, D. A.: State-dependent learning produced by alcohol and its relevance to alcoholism. In: Kissin, B.; Begleiter, H., eds. The biology of alcoholism, vol. 2. Physiology and behavior. New York: Plenum Press; 1972:193–217.
Overton, 1974, Experimental methods for the study of state-dependent learning, Fed. Proc., 33, 1800
Overton, 1978, Discriminable effects of antihistamine drugs, Arch. Int. Pharmacodyn., 232, 221
Overton, 1982, Comparison of the degree of discriminability of various drugs using the T-maze drug discrimination paradigm, Psychopharmacology (Berlin), 76, 385, 10.1007/BF00449130
Pauwels, 1998, Amino acid domains involved in constitutive activation of G-protein-coupled receptors, Mol. Neurobiol., 17, 109, 10.1007/BF02802027
Poling, 1979, Discriminative stimulus properties of phencyclidine, Neuropharmacology, 18, 459, 10.1016/0028-3908(79)90070-4
Preston, 1991, Drug discrimination methods in human drug abuse liability evaluation, Br. J. Addict., 86, 1587, 10.1111/j.1360-0443.1991.tb01752.x
Preston, 1991, Subjective and discriminative effects of drugs, Behav. Pharmacol., 2, 293, 10.1097/00008877-199109000-00006
Reavill, 1990, Behavioural and pharmacokinetic studies on nicotine, cytosine and lobeline, Neuropharmacology, 29, 619, 10.1016/0028-3908(90)90022-J
Rees, 1987, Pentobarbital like discriminative properties of halothane, 1,1,1-trichloroethane, isoamyl nitrite, flurothyl and oxazepam in mice, J. Pharmacol. Exp. Ther., 241, 507
Rees, 1987, Toluene halothane 1,1,1-trichloroethane and oxazepam produce ethanol like discriminative stimulus effects in mice, J. Pharmacol. Exp. Ther., 243, 931
Riley, 1991, A demonstration of the graded nature of the generalization function of drug discrimination learning within the conditioned taste aversion procedure, Behav. Pharmacol., 2, 323, 10.1097/00008877-199109000-00009
Riley, 1995, Use of drug discrimination learning in behavioural toxicology, 309
Rosecrans, 1977, Cholinergic and noncholinergic aspects of the discriminative stimulus properties of nicotine, 155
Rosecrans, 1978, The discriminative stimulus properties of n- and m-cholinergic receptor stimulants, 119
Sanger, 1988, Behavioural effects of the alpha-2 adrenoreceptor antagonists idazoxan and yohimbine in rats, Psychopharmacology (Berlin), 96, 243, 10.1007/BF00177568
Schuh, 1994, Insulin, 2-deoxy-d-glucose and food deprivation as discriminative stimuli in rats, Pharmacol. Biochem. Behav., 47, 317, 10.1016/0091-3057(94)90016-7
Schuster, 1977, The discriminative stimulus properties of drugs, 85, 10.1016/B978-0-12-004701-7.50008-3
Schuster, 1985, Efficacy, dependence potential and neurotoxicity of anorectic drugs, 263
Schuster, 1988, Relationship between the discriminative stimulus properties and subjective effects of drugs, 161
Shannon, 1976, Evaluation of the discriminative effects of morphine in the rat, J. Pharmacol. Exp. Ther., 198, 54
Shearman, 1979, Discriminative stimulus properties of pentylenetetrazol and bemegride, Psychopharmacology (Berlin), 64, 315, 10.1007/BF00427516
Sherrington, 1906
Spealman, 1988, Discriminative stimulus effects of adenosine analogs, J. Pharmacol. Exp. Ther., 246, 610
Stolerman, 1982, Further analysis of the nicotine cue in rats, 203
Stolerman, I. P.: Psychopharmacology of nicotine: Stimulus effects and receptor mechanisms. In: Iversen, L. L.; Iversen, S. D.; Snyder, S. H., eds. Handbook of psychopharmacology, vol. 19. New York: Plenum; 1987:421–465.
Stolerman, 1990, The European Behavioural Pharmacology Society, Psychopharmacology (Berlin), 101, 289, 10.1007/BF02244045
Stolerman, 1991, Measures of stimulus generalization in drug discrimination experiments, Behav. Pharmacol., 2, 265, 10.1097/00008877-199109000-00003
Stolerman, I. P.; Kamien J. B.: The drug discrimination database on the world wide web. Http://www.dd.database.org; 1998.
Swanson, 1978, The 2 × 2 design reconsidered, 467
Van Ree, 1979, Dependence creating properties of lipotropin C-fragment (B-endorphin), Life Sci., 24, 495, 10.1016/0024-3205(79)90170-X
Walker, 1994, In vivo apparent pA2 analysis for naltrexone antagonism of discriminative stimulus and analgesic effects of opiate agonists in rats, J. Pharmacol. Exp. Ther., 271, 959
Weathersby, 1986, Dopamine D2 receptor mediation of the discriminative stimulus properties of LY 171555 (quinpirole), Eur. J. Pharmacol., 132, 87, 10.1016/0014-2999(86)90016-6
Weingartner, 1978, Human state-dependent learning, 363
Weissman, 1976, The discriminability of aspirin in arthritic and nonarthritic rats, Pharmacol. Biochem. Behav., 5, 583, 10.1016/0091-3057(76)90273-2
Wessinger, 1987, The discriminative stimulus properties of barbiturate stereoisomers, Psychopharmacology (Berlin), 92, 334, 10.1007/BF00210840
White, 1977, Discriminative stimulus properties of quipazine, Neuropharmacology, 16, 827, 10.1016/0028-3908(77)90144-7
Winger, 1982, Discriminative stimulus effects of pentobarbital in rhesus monkeys, Psychopharmacology (Berlin), 76, 172, 10.1007/BF00435273
Winter, 1978, Stimulus properties of phenethylamine hallucinogens and lysergic acid diethylamide, J. Pharmacol. Exp. Ther., 204, 416
Winter, 1985, Sedation and the stimulus properties of antihistamines, Pharmacol. Biochem. Behav., 22, 15, 10.1016/0091-3057(85)90478-2
Wood, 1989, Mediation in the nucleus accumbens of the discriminative stimulus produced by cocaine, Pharmacol. Biochem. Behav., 33, 453, 10.1016/0091-3057(89)90529-7
Woods, 1988, Receptor mechanisms of opioid drug discrimination, 95
Woolverton, 1985, Effects of selective dopamine receptor agonists in rats trained to discriminate apomorphine from saline, Pharmacol. Biochem. Behav., 22, 577, 10.1016/0091-3057(85)90278-3
Young, 1987, Stimulus properties of benzodiazepines, Psychopharmacology (Berlin), 93, 529, 10.1007/BF00207248
Young, 1989, Tolerance to drug discriminative stimuli, 221
Young, 1991, The time is ripe for an experimental analysis of measurement issues. Commentary on Stolerman “Measurement issues in drug discrimination.”, Behav. Pharmacol., 2, 287, 10.1097/00008877-199109000-00005
Zhang, 1991, Imipramine as discriminative stimulus, J. Pharmacol. Exp. Ther., 259, 1088